Lv4
488 积分 2023-11-19 加入
Who wins the combat, CAR or TCR?
9天前
已完结
肺孢子菌肺炎的临床研究进展
3个月前
已完结
Assessment of Riociguat-related adverse events: a disproportionality analysis utilizing the FDA adverse event reporting system database
3个月前
已完结
Assessment of Riociguat-related adverse events: a disproportionality analysis utilizing the FDA adverse event reporting system database
4个月前
已完结
CAR-redirected natural killer T cells demonstrate superior antitumor activity to CAR-T cells through multimodal CD1d-dependent mechanisms
5个月前
已完结
Optimizing CAR T cell therapy for solid tumours: a clinical perspective
5个月前
已完结
Assessment of Riociguat-related adverse events: a disproportionality analysis utilizing the FDA adverse event reporting system database
5个月前
已完结
Intratumoral Injection of Clostridium novyi-NT Spores in Patients with Treatment-refractory Advanced Solid Tumors
5个月前
已完结
New therapies for nontuberculous mycobacterial lung infection
6个月前
已完结
Harnessing the Engineered Probiotic‐Nanosystem to Remodulate Tumor Extracellular Matrix and Regulate Tumor‐Colonizing Bacteria for Improving Pancreatic Cancer Chemo‐Immunotherapy
6个月前
已完结
皖公网安备34019202002308
